Avis Nancy E, Colvin Alicia, Bromberger Joyce T, Hess Rachel, Matthews Karen A, Ory Marcia, Schocken Miriam
Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1063, USA.
Menopause. 2009 Sep-Oct;16(5):860-9. doi: 10.1097/gme.0b013e3181a3cdaf.
The aim of this study was to examine changes in health-related quality of life (HRQL) during the menopausal transition, controlling for chronological aging, symptoms, and other covariates.
This was a prospective, longitudinal study of women aged 42 to 52 years at baseline recruited at seven US sites (N = 3,302) in the multiethnic Study of Women's Health Across the Nation. Women eligible for the cohort had an intact uterus, had at least one ovary, were not currently using exogenous hormones, were either premenopausal or early perimenopausal, and were self-identified as one of the study's designated racial/ethnic groups. Data from the baseline interview and six annual follow-up visits are reported. HRQL was assessed with five subscales from the Medical Outcomes Study Short-Form Health Survey, with reduced functioning defined as being in the lowest 25% on a subscale. Covariates included symptoms, medical conditions, sociodemographics variables, physical activity, and psychological factors.
With adjustment for baseline age, chronological aging, and relevant covariates, the odds of reduced role-physical functioning were significantly greater at late perimenopause (odds ratio, 1.46; 95% CI, 1.08-1.99) and postmenopause (odds ratio, 1.49; 95% CI, 1.09-2.04) compared with premenopause. Menopause status was unrelated to bodily pain, vitality, role-emotional, or social functioning. Hormone therapy users were more likely to report reduced functioning. Other variables significantly related to HRQL across all domains included vasomotor symptoms, urine leakage, poor sleep, arthritis, depressed mood, perceived stress, and stressful life events.
The menopausal transition showed little impact on HRQL when adjusted for symptoms, medical conditions, and stress.
本研究旨在探讨在控制实际年龄、症状及其他协变量的情况下,绝经过渡期间健康相关生活质量(HRQL)的变化。
这是一项前瞻性纵向研究,在美国七个地点招募了3302名基线年龄为42至52岁的女性,该研究是全国多民族女性健康研究的一部分。符合队列研究条件的女性子宫完整、至少有一个卵巢、目前未使用外源性激素、处于绝经前或围绝经期早期,且自我认定为研究指定的种族/族裔群体之一。报告了基线访谈和六次年度随访的数据。采用医学结局研究简短健康调查问卷的五个分量表评估HRQL,功能下降定义为在某个分量表上处于最低的25%。协变量包括症状、医疗状况、社会人口统计学变量、身体活动和心理因素。
在对基线年龄、实际年龄和相关协变量进行调整后,与绝经前相比,围绝经期晚期(优势比,1.46;95%可信区间,1.08 - 1.99)和绝经后(优势比,1.49;95%可信区间,1.09 - 2.04)角色 - 身体功能下降的几率显著更高。绝经状态与身体疼痛、活力、角色 - 情感或社会功能无关。激素治疗使用者更有可能报告功能下降。在所有领域中,与HRQL显著相关的其他变量包括血管舒缩症状、尿失禁、睡眠不佳、关节炎、情绪低落、感知压力和应激性生活事件。
在对症状、医疗状况和压力进行调整后,绝经过渡对HRQL的影响很小。